Page last updated: 2024-10-22

ag-1296 and Autoimmune Diseases

ag-1296 has been researched along with Autoimmune Diseases in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baroni, SS1
Santillo, M1
Bevilacqua, F1
Luchetti, M1
Spadoni, T1
Mancini, M1
Fraticelli, P1
Sambo, P1
Funaro, A1
Kazlauskas, A1
Avvedimento, EV1
Gabrielli, A1

Other Studies

1 other study available for ag-1296 and Autoimmune Diseases

ArticleYear
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    The New England journal of medicine, 2006, Jun-22, Volume: 354, Issue:25

    Topics: Adult; Aged; Animals; Autoantibodies; Autoimmune Diseases; Biological Assay; Case-Control Studies; C

2006